{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"description":"Number of participants who died after 4 weeks of treatment.","groups":[{"description":"See Detailed Description.\n\nClofarabine: Given IV\n\nCytarabine: Given IV\n\nDexamethasone: Given IV\n\nIdarubicin: Given IV\n\nRituximab: Given IV\n\nSorafenib: Given PO\n\nSorafenib Tosylate: Given PO\n\nVincristine: Given IV\n\nVincristine Sulfate: Given IV","id":"OG000","title":"Treatment (Combination Chemotherapy)"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"At 4 weeks","title":"4-week Mortality Rate","type":"SECONDARY","unitOfMeasure":"Participants"}